October 18, 2021
Home Archive by category COVID-19
Astrazeneca CDC COVID-19 emergent fda india public health Science Technology vaccine

Contractor that ruined 15M doses of J&J vaccine is holding up vaccine to India

Enlarge / Funeral pyres of people who died of COVID-19 being prepared simultaneously at Gazipur crematorium on April 26, 2021 in New Delhi, India. Getty | Raj K RajIndia’s skyrocketing surge of COVID-19 cases has launched the country into the most harrowing crisis yet in the pandemic. While international aid pours into the country, many have called...
Coronavirus COVID-19 Infectious disease pandemic public health Science Technology vaccine vaccine hesitancy

US COVID vaccinations fall nearly 11% in a week as demand wanes

Enlarge / Nurses wait at empty tables for more patients to arrive to receive a dose of the Moderna Covid-19 vaccine at a pop-up vaccination site in Gardena, California on April 17, 2021.Getty | Patrick FallonThough COVID-19 vaccines are now open to all US adults, vaccinations in the country are on the decline. In the past week, the rolling seven-da...
anthrax Clyburn COVID-19 cross contamination Emergent BioSolutions fda Infectious disease Johnson & Johnson Maloney public health Science Technology vaccines

Contractor that ruined 15M doses of J&J vaccine hiked price of another by 800%

Enlarge / The Emergent BioSolutions plant, a manufacturing partner for Johnson & Johnson's COVID-19 vaccine, in Baltimore, Maryland, on April 9, 2021. Getty | Saul LoebThings are not looking good for Emergent BioSolutions, the contract manufacturer that ruined 15 million doses of Johnson & Johnson’s one-shot COVID-19 vaccine and millions mo...
CDC COVID-19 fda hesitance Johnson & Johnson poll public health Science Technology vaccine

Pause of J&J vaccine was the right call, say 88% of polled Americans

Enlarge / General exterior view of the head office of Janssen pharmaceutical company on April 15, 2021 in Leiden, Netherlands. Getty | BSR AgencyAbout 88 percent of Americans support the pause of Johnson & Johnson’s COVID-19 vaccine, and the pause did not increase vaccine hesitancy, according to fresh data from the Axios-Ipsos Coronavirus poll....
CDC Coronavirus COVID-19 fda Infectious disease Johnson & Johnson pandemic SARS-CoV-2 Science Technology vaccine

More J&J troubles: Vaccine manufacturing halted and more possible clot cases

Enlarge / The Emergent BioSolutions plant, a manufacturing partner for Johnson & Johnson's Covid-19 vaccine, in Baltimore, Maryland, on April 9, 2021. Getty | Saul LoebThe US Food and Drug Administration last week asked Emergent BioSolutions to stop making Johnson & Johnson’s COVID-19 vaccine at its troubled facility in Baltimore, according...
CDC COVID-19 immunity Infectious disease public health Science Technology vaccination vaccines

At 38.5% vaccinated, US may be running low on people eager for a shot

Enlarge / Residents wear protective masks while waiting to be vaccinated at a West Virginia United Health System Covid-19 vaccine clinic in Morgantown, West Virginia, U.S., on Thursday, March 11, 2021. Getty | BloombergThe US logged another 4 million or so vaccinations Friday, bringing the total doses administered in the country over 200 million at...
breakthrough CDC COVID-19 infection Infectious disease public health SARS-CoV-2 Science Technology vaccines

99.992% of fully vaccinated people have dodged COVID, CDC data shows

Enlarge / Residents wait in an observation area after receiving Covid-19 vaccines at a vaccination site in Richmond, California on Thursday, April 15, 2021. Getty | BloombergCases of COVID-19 are extremely rare among people who are fully vaccinated, according to a new data analysis by the Centers for Disease Control and Prevention. Among more than ...
ACIP CDC COVID-19 CVST Johnson & Johnson platelets Science Technology vaccine

CDC expert panel punts on deciding fate of J&J COVID vaccine

Enlarge / Boxes of Johnson & Johnson's Janssen COVID-19 vaccine at a vaccination site in Florida.Getty | Paul HennessyAn advisory committee for the Centers for Disease Control and Prevention declined to vote on the fate of Johnson & Johnson’s COVID-19 vaccine Wednesday, likely leaving in place a pause on the vaccine’s use until the committe...
Astrazeneca CDC clotting COVID-19 fda Johnson & Johnson medicine Science Technology vaccine

J&J COVID vaccine use paused due to one-in-a-million complication

Enlarge / A nurse practitioner named Heidi Johnson administers a vaccine from Johnson & Johnson.Tom Williams / Getty ImagesOn Tuesday morning, the US Centers for Disease Control and Food and Drug Administration issued a release acknowledging an extremely rare clotting disorder was associated with the use of the Johnson & Johnson COVID vacci...